- Home
- SAVA vs RRGB Comparison
SAVA vs RRGB Comparison
Compare SAVA & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- RRGB
- Stock Information
- Founded
- SAVA 1998
- RRGB 1969
- Country
- SAVA United States
- RRGB United States
- Employees
- SAVA N/A
- RRGB N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- RRGB Restaurants
- Sector
- SAVA Health Care
- RRGB Consumer Discretionary
- Exchange
- SAVA Nasdaq
- RRGB Nasdaq
- Market Cap
- SAVA 102.4M
- RRGB 88.7M
- IPO Year
- SAVA N/A
- RRGB 2002
- Fundamental
- Price
- SAVA $2.34
- RRGB $6.72
- Analyst Decision
- SAVA Hold
- RRGB Strong Buy
- Analyst Count
- SAVA 1
- RRGB 4
- Target Price
- SAVA $2.00
- RRGB $12.38
- AVG Volume (30 Days)
- SAVA 867.7K
- RRGB 351.5K
- Earning Date
- SAVA 08-14-2025
- RRGB 08-13-2025
- Dividend Yield
- SAVA N/A
- RRGB N/A
- EPS Growth
- SAVA N/A
- RRGB N/A
- EPS
- SAVA N/A
- RRGB N/A
- Revenue
- SAVA N/A
- RRGB $1,235,920,000.00
- Revenue This Year
- SAVA N/A
- RRGB N/A
- Revenue Next Year
- SAVA N/A
- RRGB N/A
- P/E Ratio
- SAVA N/A
- RRGB N/A
- Revenue Growth
- SAVA N/A
- RRGB N/A
- 52 Week Low
- SAVA $1.15
- RRGB $2.50
- 52 Week High
- SAVA $33.98
- RRGB $7.89
- Technical
- Relative Strength Index (RSI)
- SAVA 54.06
- RRGB 61.16
- Support Level
- SAVA $2.20
- RRGB $5.70
- Resistance Level
- SAVA $2.43
- RRGB $5.83
- Average True Range (ATR)
- SAVA 0.17
- RRGB 0.40
- MACD
- SAVA -0.00
- RRGB 0.03
- Stochastic Oscillator
- SAVA 60.42
- RRGB 95.31
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.